Drug intelligence / Profile preview

Bronpass

Development stage: Phase 4
Lead developer: Insmed
Administration: Oral

Overview

Bronpass is an investigational drug currently being evaluated in clinical trials for the treatment of chronic obstructive pulmonary disease (COPD)[1]. The available information indicates that it is administered in tablet form and its efficacy and safety are under investigation. The precise mechanism of action, active ingredient, developer, and other pharmacological details have not been disclosed in public sources as of now[1].

Brand names: Bronpass
Other names: Bronpass Tab

Beyond the preview

Go deeper on Bronpass.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bronpass.

Explore the full profile